259 related articles for article (PubMed ID: 28119367)
21. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
22. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
24. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
25. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
26. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
Wu J; Lai M; Shao C; Wang J; Wei JJ
Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
[TBL] [Abstract][Full Text] [Related]
27. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition.
Han Y; Ye J; Wu D; Wu P; Chen Z; Chen J; Gao S; Huang J
BMC Cancer; 2014 Dec; 14():932. PubMed ID: 25496320
[TBL] [Abstract][Full Text] [Related]
28. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
29. HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer.
Ding WJ; Zhou M; Chen MM; Qu CY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):385-397. PubMed ID: 27761656
[TBL] [Abstract][Full Text] [Related]
30. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
31. miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2.
Chen Z; Li Q; Wang S; Zhang J
Int J Mol Med; 2015 Oct; 36(4):1136-42. PubMed ID: 26239806
[TBL] [Abstract][Full Text] [Related]
32. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer.
Hawsawi O; Henderson V; Burton LJ; Dougan J; Nagappan P; Odero-Marah V
Biochem Biophys Res Commun; 2018 Sep; 504(1):196-202. PubMed ID: 30177390
[TBL] [Abstract][Full Text] [Related]
33. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
34. The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer.
Yu WW; Jiang H; Zhang CT; Peng Y
Oncotarget; 2017 Jun; 8(24):39280-39295. PubMed ID: 28424413
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
36. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
37. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
38. Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT.
Li W; Li S; Deng L; Yang S; Li M; Long S; Chen S; Lin F; Xiao L
Tumour Biol; 2015 Sep; 36(9):6883-9. PubMed ID: 25851348
[TBL] [Abstract][Full Text] [Related]
39. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
